News about genomics analysis tools including next generation sequencing, electrophoresis, PCR, and others
December 15, 2020 SOUTH SAN FRANCISCO, Calif., Dec. 15, 2020 (GLOBE NEWSWIRE) — Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today announced the appointment of Dr. Ana K. Stankovic, MD, PhD, MSPH, to the company’s Board of Directors. Dr. Stankovic is a seasoned leader with more than 30 years of research... Read more
Tue 15th December 2020 Oxford Nanopore’s rapid LamPORE COVID-19 test to be made available via SourceBio accredited lab facilities. Oxford Nanopore Technologies Limited (“Oxford Nanopore”), a leading next generation DNA/RNA sequencing technology company and SourceBio International plc (“SourceBio”), an international provider of integrated state of the art laboratory services and products, announce a strategic commercial... Read more
Company expands testing portfolio for acute diagnostics of COVID-19 WALTHAM, Mass. – December 14, 2020 – EUROIMMUN, a PerkinElmer, Inc. Company, today announced the launch of the CE marked EURORealTime SARS-CoV-2/Influenza A/B for direct detection of SARS-CoV-2, influenza virus type A and influenza virus type B. It expands the testing portfolio for acute COVID-19 diagnostics... Read more
MENLO PARK, Calif., Dec. 14, 2020 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (Nasdaq:PACB), a leading provider of high-quality sequencing of genomes, transcriptomes and epigenomes, today announced that three of the United Kingdom’s leading core laboratories have increased their investment in the company’s Single Molecule, Real-Time (SMRT®) Sequencing technology. Edinburgh Genomics, Oxford Genomics Centre,... Read more
Edinburgh Genomics, Oxford Genomics Centre, and University of Liverpool Centre for Genomic Research have added new PacBio Sequel II & IIe Systems to their service laboratories Edinburgh Genomics, Oxford Genomics Centre, and University of Liverpool Centre for Genomic Research have added new PacBio Sequel II & IIe Systems to their service laboratories Read more
Posted December 10, 2020 For Immediate Release Weston Umstead, Ph.D. Promoted to Technology & Business Development Manager for Chiral Technologies, Inc. WEST CHESTER, Pa (December 10, 2020) — Chiral Technologies, Inc. today announced the promotion of Weston Umstead, Ph.D., as the company’s new Technology and Business Development Director. Umstead joined Chiral Technologies in 2016 as... Read more
SAN DIEGO & WELLESLEY, Mass.–(BUSINESS WIRE)–Illumina, Inc. (Nasdaq: ILMN) and Harvard Pilgrim Health Care announce a risk-sharing agreement to make whole-genome sequencing (WGS) available to certain Harvard Pilgrim members, effective January 1, 2021. The program will leverage WGS to support faster diagnoses of genetic diseases in children, potentially eliminating the long, costly diagnostic odyssey experienced... Read more
December 3, 2020 at 10:00 AM EST CINCINNATI, Dec. 03, 2020 (GLOBE NEWSWIRE) — Meridian Bioscience, Inc. (NASDAQ: VIVO), a leading global provider of diagnostic testing solutions and life science raw materials, announced today that it has launched an Air-Dryable RT-qPCR Mix, driving innovation in the development of molecular tests with ambient temperature stability. This specialized master mix is designed... Read more
Combination of free user-friendly web tool, to obtain custom probe sequences, and enzyme-based technology allows for efficient depletion of abundant RNAs for virtually any organism and sample type. IPSWICH, MA (December 1, 2020): Today, New England Biolabs (NEB®) announced further expansion of its RNA depletion product portfolio with the launch of the NEBNext Custom RNA... Read more